Table 3 Amblyopia patients’ main data (Refraction correction can be either Spherical — sph or Cylindrical — cyl).
Name | AL | BA | BY | BM | BS | BA | RS | CF | CG | CA | PA | MG | PD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Age (y) | 7 | 11 | 5 | 9 | 9 | 6 | 8 | 9 | 3 | 6 | 5 | 8 | 5 |
Sex (M/F) | M | F | F | M | F | F | F | F | F | F | F | F | F |
Refraction right eye | cyl. +1.50 95° | None | None | sph. +2.50 = cyl. +0.50 20° | None | cyl. +0.50 90° | cyl. +1 90° | sph. -0.50 = cyl. -1 180° | sph. +3.50 = cyl. +0.50 90° | cyl. +2.50 80° | sph. +3.50 | sph. +0.50 = cyl. +2 95° | cyl. +2.50 90° |
Refraction left eye | cyl. +1 90° | None | sph. + 2 | None | None | None | sph. -1 = cyl. +3 90° | sph. -0.50 = cyl. -1 180° | None | cyl. +2.50 90° | sph. +1.50 | sph. +0.50 = cyl. +4 90° | cyl. +3 90° |
First treatment | |||||||||||||
Evaluation in Month/year | May/13 | Jan/12 | Feb/14 | Mar/11 | Apr/14 | Oct/13 | Jan/13 | Sep/12 | May/11 | Feb/12 | Mar/12 | Jun/12 | Jun/12 |
BCVA RE | 20/25 | 20/22 | 20/20 | 20/22 | 20/25 | 20/33 | 20/24 | 20/33 | 20/40 | 20/28 | 20/28 | 20/30 | 20/33 |
BCVA LE | 20/20 | 20/22 | 20/25 | 20/13 | 20/25 | 20/20 | 20/25 | 20/33 | 20/13 | 20/28 | 20/28 | 20/33 | 20/33 |
Number of treatments Sessions | 7 | 4 | 11 | 8 | 6 | 10 | 8 | 12 | 6 | 9 | 9 | 8 | 5 |
Evaluation out | |||||||||||||
Month/year | Jul/13 | Feb/12 | Jun/14 | May/11 | Jun/14 | Dec/13 | Mar/13 | Nov/12 | Jun/11 | Jun/12 | May/12 | Jul/12 | Jul/12 |
BCVA RE | 20/20 | 20/20 | 20/20 | 20/20 | 20/25 | 20/28 | 20/20 | 20/20 | 20/33 | 20/20 | 20/22 | 20/22 | 20/25 |
BCVA LE | 20/20 | 20/20 | 20/20 | 20/13 | 20/25 | 20/20 | 20/22 | 20/20 | 20/13 | 20/20 | 20/22 | 20/30 | 20/25 |
Second treatment | |||||||||||||
Evaluation in | |||||||||||||
Month/year | Sep/13 | Nov/11 | Jun/13 | Sep/11 | Jun/13 | Oct/14 | Jan/13 | Mar/13 | |||||
BCVA RE | 20/23 | 20/22 | 20/22 | 20/33 | 20/22 | 20/28 | 20/22 | 20/28 | |||||
BCVA LE | 20/20 | 20/13 | 20/22 | 20/13 | 20/22 | 20/28 | 20/25 | 20/25 | |||||
Number of treatments | |||||||||||||
Sessions | 8 | 4 | 6 | 4 | 7 | 14 | 4 | ||||||
Evaluation out | |||||||||||||
Month/year | Jan/14 | Dec/11 | Jun/13 | Oct/11 | Jul/13 | Nov/14 | Jun/13 | Mar/13 | |||||
BCVA RE | 20/20 | 20/21 | 20/20 | 20/33 | 20/22 | 20/22 | 20/20 | 20/25 | |||||
BCVA LE | 20/20 | 20/13 | 20/20 | 20/13 | 20/22 | 20/22 | 20/20 | 20/22 | |||||
Third treatment | |||||||||||||
Evaluation in | |||||||||||||
Month/year | Oct/12 | Jun/14 | May/14 | ||||||||||
BCVA RE | 20/21 | 20/22 | 20/20 | ||||||||||
BCVA LE | 20/13 | 20/22 | 20/22 | ||||||||||
Number of treatments | |||||||||||||
Sessions | 7 | 4 | 10 | ||||||||||
Evaluation out | |||||||||||||
Month/year | Dec/12 | Jul/14 | Nov/14 | ||||||||||
BCVA RE | 20/21 | 20/20 | 20/20 | ||||||||||
BCVA LE | 20/13 | 20/20 | 20/22 | ||||||||||
Control visit | |||||||||||||
Month/year | Oct/14 | Sep/14 | Mar/15 | Nov/14 | Mar/15 | Oct/14 | Apr/14 | Mar/15 | Oct/13 | ||||
BCVA RE | 20/20 | 20/20 | 20/20 | 20/21 | 20/28 | 20/20 | 20/20 | 20/20 | 20/22 | ||||
BCVA LE | 20/20 | 20/20 | 20/20 | 20/13 | 20/20 | 20/20 | 20/20 | 20/20 | 20/22 | ||||
P | P | P | N | N | P | P | P | P | P | P | P | P |